NASDAQ:CTXR

Citius Pharmaceuticals Stock Forecast

etoro logo Buy CTXR
*Your capital is at risk
$0.540
-0.0051 (-0.94%)
At Close: Jun 26, 2026
AI Analysis AI Analysis of CTXR AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CTXR to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Citius Pharmaceuticals Inc
(Updated on Jun 26, 2026)

Sell candidate since Apr 24, 2026 Loss -29.87%

The Citius Pharmaceuticals Inc stock price fell by -0.94% on the last day (Friday, 26th Jun 2026) from $0.545 to $0.540. During the last trading day the stock fluctuated 4.69% from a day low at $0.540 to a day high of $0.565. The price has fallen in 5 of the last 10 days and is down by -5.69% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -174 thousand shares and in total, 0 shares were bought and sold for approximately $0 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -32.71% during the next 3 months and, with a 90% probability hold a price between $0.235 and $0.467 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CTXR Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Citius Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.553 and $0.602. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, June 24, 2026, and so far it has fallen -5.26%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Citius Pharmaceuticals Inc stock

Citius Pharmaceuticals Inc finds support from accumulated volume at $0.527 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.0253 between high and low, or 4.69%. For the last week the stock has had daily average volatility of 6.17%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CTXR) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Citius Pharmaceuticals Inc to open at $0.548, and during the day (based on 14 day Average True Range), to move between $0.516 and $0.564, which gives a possible trading interval of +/-$0.0471 (+/-9.12%) up or down from last closing price. If Citius Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 9.12% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.527 (2.41%) than the resistance at $0.595 (10.20%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Citius Pharmaceuticals Inc stock A Buy?

Citius Pharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.588 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $0.548 ( 1.56%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CTXR Performance

Trading levels for CTXR

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.574 6.25%
R2 0.564 4.46%
R1 0.558 3.35%
Price 0.540
S1 0.539 -0.228%
S2 0.533 -1.33%
S3 0.523 -3.12%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.653 20.91%
R2 0.650 20.39%
R1 0.595 10.20%
Price 0.540
S1 0.527 -2.41%
S2 0 -
S3 0 -

FAQ

What is the symbol for Citius Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Citius Pharmaceuticals Inc is CTXR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Citius Pharmaceuticals Inc Stock?
Citius Pharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Citius Pharmaceuticals Inc Stock?
Citius Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Citius Pharmaceuticals Inc Stock.

What's the current price of Citius Pharmaceuticals Inc Stock?
As of the end of day on the Jun 26, 2026, the price of an Citius Pharmaceuticals Inc (CTXR) share was $0.540.

What is the 52-week high and low for Citius Pharmaceuticals Inc Stock?
The 52-week high for Citius Pharmaceuticals Inc Stock is $2.48 and the 52-week low is $0.476.

What is the market capitalization of Citius Pharmaceuticals Inc Stock?
As of the Jun 26, 2026, the market capitalization of Citius Pharmaceuticals Inc is 6.034M.

When is the next earnings date for Citius Pharmaceuticals Inc?
The upcoming earnings date for Citius Pharmaceuticals Inc is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT CITIUS PHARMACEUTICALS INC
Citius Pharmaceuticals
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected c...
GOLDEN STAR
Ticker Change Signal Date
JLL
$299.78
5.10% Jun 24
X
XMAX
$8.34
5.40% Jun 24
TWI
$7.56
6.08% Jun 22
IAC
$42.63
5.08% Jun 12
DHI
$146.71
13.35% Jun 10

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE